What documents are included for customs clearance?

We provide a full set including Phytosanitary Certificate, Certificate of Origin, Invoice, Packing List, and Air Waybill.

Is technical support available after purchase?

Yes, we offer year-round online consultation in English and Chinese for cultivation and pest control.

Ficus Aspera Tissue Culture Clumps Single Shoot Plants Rooting Stage

Name: Ficus Aspera Tissue Culture Clumps Single Shoot Plants Rooting Stage
Brand: Foshan Sanshui Youngplants Co., Ltd.
SKU: 2238795305

Guangdong, ChinaFoshan Sanshui Youngplants Co., Ltd.

US$0.23-0.30

100 Pieces

Product profile

Customization

Available

Growth Environment

Subtropical

Watch Parts

Leaf

Model NO.

TC/128

Scent

Odorless

Size

Large

Application

Outdoor, Indoor

Type

Potted Flowers

Family

Moraceae

Transportation

by Air

Transport Package

Carton/Foam Box

Specification

POT

Trademark

YoungPlants

Origin

Foshan

HS Code

0602909199

Production Capacity

300000

Key features

Full-Process Service System: End-to-end solutions from demand docking to after-sales support for tissue culture plants.

Fast Delivery Cycle: Order delivery is 30% faster than industry average (TC: 25-30 days, Plugs: 15-20 days).

ODM/OEM Customization: Support for customized variety labels, packaging, and special variety development.

ISO Quality Management: ISO-certified quality management with 100% pre-shipment inspection including pest testing.

Global Service Network: Over 15 years of experience serving clients in 50+ countries with market compliance expertise.

Comprehensive Documentation: Full set of documents provided including Phytosanitary Certificate, CO, and Air Waybill.

Visual Progress Tracking: Real-time photo updates on growth and packing plans 1 month and 1 week before shipment.

After-Sales Guarantee: Replacement or refund within 15 working days for plant-related losses within 7 days of arrival.

Company profile

Foshan Sanshui Youngplants Co., Ltd.

Guangdong, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2008-08-31 CertifiedNearest Port: Foshan Port, Shenzhen PortAverage Response Time: ≤8.09hTerms of Payment: T/T

AI-Powered supplier vetting

SummaryFoshan Youngplants is a China-based limited company and factory specializing in tissue culture plants. It was established in 2008, began exporting in 2008, and reports that 71%–90% of sales come from exports. The supplier identifies 30,000 m² of manufacturing area, six in vitro laboratories covering more than 9,000 m², ten production lines, and 50 quality-control staff. It reports over 80 million annual output and serves markets including Japan, South Korea, Australia, and domestic customers. Evidence also indicates AEO, high-technology, nursery, and model laboratory honors, although certification details and validity are not provided. The supplier’s innovation, customization, after-sales, financial credibility, and customer-case strength cannot be fully verified from the supplied information.

Supplier typeThe supplier is identified as a limited company, factory, and combined business entity operating in Foshan, Guangdong, China. Its stated agricultural and biotechnology focus, together with tissue-culture production facilities, supports classification as a manufacturing supplier rather than only a trading intermediary.

CertificationsThe supplier states that it has received an Authorized Economic Operator (AEO) Certificate and honors including “One of The Best Nurseries,” “Model Tissue Culture Lab,” and “High Technology Expertise.” However, the slices do not provide certificate numbers, issuing dates, scope, or current validity.

R&D capabilityThe supplier specializes in in vitro tissue culture, operates six laboratories, reports more than 70 technologists and management personnel in one company description, and highlights innovation and new-cultivar cooperation. It also states that it has received high-technology recognition, providing positive evidence of technical capability, although R&D staffing information is inconsistent across slices and specific innovations are not documented.

Production capacityProduction evidence includes a stated annual output exceeding 80 million, a 30,000 m² manufacturing plant, six tissue-culture laboratories covering more than 9,000 m², ten production lines, and 50 quality-control staff. The supplier also reports one-month order fulfillment in both peak and off-peak seasons, indicating substantial stated capacity, although the output figure is presented in a company description without product-unit clarification.